The invention relates to novel CD1a-presented antigens. These antigens can be used as antigens, adjuvants or as immunomodulatory agents in a variety of diagnostic, therapeutic and prophylactic applications.

 
Web www.patentalert.com

> Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens

~ 00367